Skip to main content

Navigation group

Type at least 3 characters
2,003 articles

Articles

Original Research

Published on 31 Mar 2022

Humoral and Cellular Immunogenicity and Safety of Five Different SARS-CoV-2 Vaccines in Patients With Autoimmune Rheumatic and Musculoskeletal Diseases in Remission or With Low Disease Activity and in Healthy Controls: A Single Center Study

in T Cell Biology

  • Gábor J. Szebeni
  • Nikolett Gémes
  • Dániel Honfi
  • Enikő Szabó
  • Patrícia Neuperger
  • József Á. Balog
  • Lajos I. Nagy
  • Zoltán Szekanecz
  • László G. Puskás
  • Gergely Toldi
Humoral and Cellular Immunogenicity and Safety of Five Different SARS-CoV-2 Vaccines in Patients With Autoimmune Rheumatic and Musculoskeletal Diseases in Remission or With Low Disease Activity and in Healthy Controls: A Single Center Study
Frontiers in Immunology
doi 10.3389/fimmu.2022.846248
  • 5,629 views
  • 21 citations